Terpenoid ID | TKC053751 | |
Chirality | TKC102941 | |
Cell line | 0 | |
Protein target | 19 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 31 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC053751 | Vero | VERO; VeroCCL81; Vero 81; Vero-81; Verda reno | 106.0 | ug.mL-1 | IC50 | ||
TKC053751 | HeLa | HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri | 100000.0 | nM | IC50 | C27677 | |
TKC053751 | U-87 MG | 100000.0 | nM | IC50 | C3058 | Orphanet_360 | |
TKC053751 | MKN-45 | MKN-45; MKN 45 | 100000.0 | nM | IC50 | C4004 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC053751 | P10636 | Microtubule-associated protein tau | MAPT | 5623 | nM | Potency |
TKC053751 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 18356 | nM | Potency |
TKC053751 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 58 | % | Inhibition |
TKC053751 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 40 | % | Inhibition |
TKC053751 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 39811 | nM | Potency |
TKC053751 | P08183 | ATP-dependent translocase ABCB1 | ABCB1 | 88 | % | Survival |
TKC053751 | O75496 | Geminin | GMNN | 29093 | nM | Potency |
TKC053751 | P39748 | Flap endonuclease 1 | FEN1 | 26680 | nM | Potency |
TKC053751 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | PIN1 | 79433 | nM | Potency |
TKC053751 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 24 | nM | Potency |
TKC053751 | O00255 | Menin | MEN1 | 14125 | nM | Potency |
TKC053751 | P25779 | Cruzipain | 3162 | nM | Potency | |
TKC053751 | P10520 | Streptokinase A | ska | 362 | nM | EC50 |
TKC053751 | O15438 | ATP-binding cassette sub-family C member 3 | ABCC3 | 133000 | nM | IC50 |
TKC053751 | O15439 | ATP-binding cassette sub-family C member 4 | ABCC4 | 133000 | nM | IC50 |
TKC053751 | O95342 | Bile salt export pump | ABCB11 | 10100 | nM | IC50 |
TKC053751 | O95342 | Bile salt export pump | ABCB11 | 11500 | nM | IC50 |
TKC053751 | O95342 | Bile salt export pump | ABCB11 | 10100 | nM | IC50 |
TKC053751 | Q92887 | ATP-binding cassette sub-family C member 2 | ABCC2 | 133000 | nM | IC50 |
TKC053751 | Q194T2 | Non-structural protein 1 | NS1 | 7943 | nM | Potency |
TKC053751 | O15648 | ATP-dependent 6-phosphofructokinase | pfk | 7569 | nM | Potency |
TKC053751 | P02768 | Albumin | ALB | 12000 | nM | Kd |
TKC053751 | O70127 | Bile salt export pump | Abcb11 | 2200 | nM | Ki |
TKC053751 | O70127 | Bile salt export pump | Abcb11 | 17400 | nM | IC50 |
TKC053751 | Q63120 | ATP-binding cassette sub-family C member 2 | Abcc2 | 5500 | nM | Ki |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P10636 | TAU_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 | TAU_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P10636 | TAU_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 | TAU_HUMAN | Choreiform disorder [ICD-11: 8A01] |
P10636 | TAU_HUMAN | Parkinsonism [ICD-11: 8A00] |
P10636 | TAU_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 | TAU_HUMAN | Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
P08183 | MDR1_HUMAN | Lung cancer [ICD-11: 2C25] |
P08183 | MDR1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08183 | MDR1_HUMAN | Bacterial infection [ICD-11: 1A00-1C4Z] |
P08183 | MDR1_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P08183 | MDR1_HUMAN | Adrenal cancer [ICD-11: 2D11] |
P08183 | MDR1_HUMAN | Ovarian cancer [ICD-11: 2C73] |
Q13526 | PIN1_HUMAN | Lung cancer [ICD-11: 2C25] |
Q13526 | PIN1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P25779 | CYSP_TRYCR | Parasitic worm infestation [ICD-11: 1F90] |
P25779 | CYSP_TRYCR | Malaria [ICD-11: 1F40-1F45] |
P02768 | ALBU_HUMAN | Aneurysm/dissection [ICD-11: BD50] |
P02768 | ALBU_HUMAN | Bowel habit change [ICD-11: ME05] |
P02768 | ALBU_HUMAN | Cholelithiasis [ICD-11: DC11] |
P02768 | ALBU_HUMAN | Inborn energy metabolism error [ICD-11: 5C53] |
P02768 | ALBU_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
P02768 | ALBU_HUMAN | Preprocedural examination [ICD-11: QA0B] |
P02768 | ALBU_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P02768 | ALBU_HUMAN | Schizophrenia [ICD-11: 6A20] |
P02768 | ALBU_HUMAN | Unspecific body region injury [ICD-11: ND56] |
P02768 | ALBU_HUMAN | Coagulation defect [ICD-11: 3B10] |
P02768 | ALBU_HUMAN | Lupus erythematosus [ICD-11: 4A40] |
P02768 | ALBU_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |